Table of Contents

2019-2024 Global Pertussis Vaccine Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Pertussis Vaccine Consumption 2014-2024
  • 2.1.2 Pertussis Vaccine Consumption CAGR by Region
• 2.2 Pertussis Vaccine Segment by Type
  • 2.2.1 Whole-cell vaccines
  • 2.2.2 Acellular vaccines
• 2.3 Pertussis Vaccine Consumption by Type
  • 2.3.1 Global Pertussis Vaccine Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Pertussis Vaccine Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Pertussis Vaccine Sale Price by Type (2014-2019)
• 2.4 Pertussis Vaccine Segment by Application
  • 2.4.1 Children
  • 2.4.2 Adults
• 2.5 Pertussis Vaccine Consumption by Application
  • 2.5.1 Global Pertussis Vaccine Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Pertussis Vaccine Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Pertussis Vaccine Sale Price by Application (2014-2019)

3 Global Pertussis Vaccine by Players

• 3.1 Global Pertussis Vaccine Sales Market Share by Players
  • 3.1.1 Global Pertussis Vaccine Sales by Players (2017-2019)
  • 3.1.2 Global Pertussis Vaccine Sales Market Share by Players (2017-2019)
• 3.2 Global Pertussis Vaccine Revenue Market Share by Players
  • 3.2.1 Global Pertussis Vaccine Revenue by Players (2017-2019)
  • 3.2.2 Global Pertussis Vaccine Revenue Market Share by Players (2017-2019)
• 3.3 Global Pertussis Vaccine Sale Price by Players
• 3.4 Global Pertussis Vaccine Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Pertussis Vaccine Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Pertussis Vaccine Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Pertussis Vaccine by Regions

• 4.1 Pertussis Vaccine by Regions
  • 4.1.1 Global Pertussis Vaccine Consumption by Regions
  • 4.1.2 Global Pertussis Vaccine Value by Regions
• 4.2 Americas Pertussis Vaccine Consumption Growth
• 4.3 APAC Pertussis Vaccine Consumption Growth
• 4.4 Europe Pertussis Vaccine Consumption Growth
• 4.5 Middle East & Africa Pertussis Vaccine Consumption Growth

5 Americas

• 5.1 Americas Pertussis Vaccine Consumption by Countries
  • 5.1.1 Americas Pertussis Vaccine Consumption by Countries (2014-2019)
  • 5.1.2 Americas Pertussis Vaccine Value by Countries (2014-2019)
• 5.2 Americas Pertussis Vaccine Consumption by Type
• 5.3 Americas Pertussis Vaccine Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Pertussis Vaccine Consumption by Countries
  • 6.1.1 APAC Pertussis Vaccine Consumption by Countries (2014-2019)
  • 6.1.2 APAC Pertussis Vaccine Value by Countries (2014-2019)
• 6.2 APAC Pertussis Vaccine Consumption by Type
• 6.3 APAC Pertussis Vaccine Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Pertussis Vaccine by Countries
  • 7.1.1 Europe Pertussis Vaccine Consumption by Countries (2014-2019)
  • 7.1.2 Europe Pertussis Vaccine Value by Countries (2014-2019)
• 7.2 Europe Pertussis Vaccine Consumption by Type
• 7.3 Europe Pertussis Vaccine Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Pertussis Vaccine by Countries
  • 8.1.1 Middle East & Africa Pertussis Vaccine Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Pertussis Vaccine Value by Countries (2014-2019)
• 8.2 Middle East & Africa Pertussis Vaccine Consumption by Type
• 8.3 Middle East & Africa Pertussis Vaccine Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Pertussis Vaccine Distributors
• 10.3 Pertussis Vaccine Customer

11 Global Pertussis Vaccine Market Forecast

• 11.1 Global Pertussis Vaccine Consumption Forecast (2019-2024)
• 11.2 Global Pertussis Vaccine Forecast by Regions
  • 11.2.1 Global Pertussis Vaccine Forecast by Regions (2019-2024)
  • 11.2.2 Global Pertussis Vaccine Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Pertussis Vaccine Forecast by Type
• 11.8 Global Pertussis Vaccine Forecast by Application

12 Key Players Analysis

• 12.1 Sanofi Pasteur
  • 12.1.1 Company Details
  • 12.1.2 Pertussis Vaccine Product Offered
  • 12.1.3 Sanofi Pasteur Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Sanofi Pasteur News
• 12.2 GSK
  • 12.2.1 Company Details
  • 12.2.2 Pertussis Vaccine Product Offered
  • 12.2.3 GSK Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 GSK News
• 12.3 Mitsubishi Tanabe Pharma
  • 12.3.1 Company Details
  • 12.3.2 Pertussis Vaccine Product Offered
  • 12.3.3 Mitsubishi Tanabe Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Mitsubishi Tanabe Pharma News
• 12.4 Astellas Pharma
  • 12.4.1 Company Details
  • 12.4.2 Pertussis Vaccine Product Offered
  • 12.4.3 Astellas Pharma Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Astellas Pharma News
• 12.5 Minhai Biotechnology
  • 12.5.1 Company Details
  • 12.5.2 Pertussis Vaccine Product Offered
  • 12.5.3 Minhai Biotechnology Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Minhai Biotechnology News
• 12.6 Wuhan Institute of Biological Products
  • 12.6.1 Company Details
  • 12.6.2 Pertussis Vaccine Product Offered
  • 12.6.3 Wuhan Institute of Biological Products Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Wuhan Institute of Biological Products News
• 12.7 Changchun Changsheng Life Sciences
  • 12.7.1 Company Details
  • 12.7.2 Pertussis Vaccine Product Offered
  • 12.7.3 Changchun Changsheng Life Sciences Pertussis Vaccine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Changchun Changsheng Life Sciences News

...

13 Research Findings and Conclusion

Pertussis vaccine is a vaccine that protects against whooping cough. There are two main types: whole-cell vaccines and acellular vaccines. The whole-cell vaccine is about 78% effective while the acellular vaccine is 71–85% effective.
Manufacturers take the combination of direct Marketing channel and distribution sales in the form, Future sales channels both direct selling and distribution needs with the help of online sales platform.

The market channel is essential to every manufacturer and they are paying more and more attention to their channel building. Firstly, suppliers can build strong sales teams to directly manage their own customers. At the same time, more flexible and attractive channel incentives can be created and channel support can be provided in different ways. At the meantime, customers are concerning more on the product quality and services. So, except all of the distributors and direct marketing, they are also consider their logistics and services, making sure that both products and services are better than the competitors.

Depending on market position, make different pricing strategy. Pricing product is based on product position. Different kind of dispensers should be priced differently. It is obvious that high-end product should be expensive and low-end product should be cheap.

For the manufacturers, depreciate can bring more consumers and inflation can bring larger profit margin. When manufacturers price their products, should consider many factors like the manufacturing cost, market position and targets of price adjustment (larger profit margin, more consumers, larger market share, more order, etc.).

To build a brand admired by consumers need a long time, though the period is much shorter due to the development of advertising industry and internet. There are many ways to build a new brand, but only one way is always here, good product quality.

Today, brand strategy has been various. Some manufacturers hold their unique brand, which have been acquired by consumers. Exactly, consumers may prefer the known brand rather a new brand that they doesn’t know. On the contrary, some manufacturers may introduce several brands of their product. They featured each brand and market them for certain target client.

According to this study, over the next five years the Pertussis Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pertussis Vaccine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Pertussis Vaccine market by product type, application, key manufacturers and key regions and countries.

This study considers the Pertussis Vaccine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Whole-cell vaccines
Acellular vaccines
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Children
Adults

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of Biological Products
Changchun Changsheng Life Sciences
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Pertussis Vaccine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Pertussis Vaccine market by identifying its various subsegments.
Focuses on the key global Pertussis Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pertussis Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Pertussis Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.